In the group of patients presenting a nodular sclerosis subtype, the immune profile switched at relapse (Figure 4b and Supplementary Table S3), with an upregulation of LGALS1 and TGFB1 and downregulation of CD163, CD274, HGF, IL15, and ICOS. This evidence concerns the gene ICOS and Hodgkins lymphoma.